Zobrazeno 1 - 10
of 261
pro vyhledávání: '"Wolfgang Von Scheidt"'
Autor:
Evaldas Girdauskas, Sina Stock, Elisa Favot, Blerim Luani, Tatiana Sequeira-Gross, Christian Dumps, Maria von Stumm, Tamer Owais, Wolfgang von Scheidt
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 8, p 283 (2024)
The treatment of secondary mitral regurgitation (SMR) remains challenging despite the implementation of modern heart failure medication and established catheter-based techniques. Only a subgroup of SMR patients benefit from mitral valve (MV) interven
Externí odkaz:
https://doaj.org/article/93b4b9a98d0d45c4936b2a545796b34a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pauschinger, Matthias
Publikováno v:
Aktuelle Kardiologie; August 2023, Vol. 12 Issue: 4 p246-246, 1p
Autor:
Tamer Owais, Mohammad El Garhy, Sebastian Elvinger, Eva Harmel, Tatiana Maria Sequeria Gross, Harald Lapp, Thomas Kuntze, Wolfgang Von Scheidt, Evaldas Girdauskas, Mahmoud Al-Jassem, Philipp Lauten
Publikováno v:
The Egyptian Heart Journal, Vol 74, Iss 1, Pp 1-9 (2022)
Abstract Background Transcatheter mitral valve-in-valve (TMVIV) or valve-in-ring (TMVIR) replacement offer an alternative therapy for high risk patients. We aimed to highlight the operative and postoperative results of TMVIV and TMVIR procedures. Res
Externí odkaz:
https://doaj.org/article/70958739cdcc4453bd3cc0c00dd33f1b
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background The association between the presence of a diagonal earlobe crease (DEC) and coronary artery disease has been prescribed earlier. However, it is unclear whether patients with acute myocardial infarction (AMI) and DEC have a higher
Externí odkaz:
https://doaj.org/article/6b1459c985064c8db7bae626f421606e
Autor:
Christine Meindl, Matthias Hochadel, Lutz Frankenstein, Oliver Bruder, Matthias Pauschinger, Rainer Hambrecht, Wolfgang von Scheidt, Otmar Pfister, Andreas Hartmann, Lars S Maier, Jochen Senges, Bernhard Unsöld
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234260 (2020)
BackgroundType 2 diabetes is a major risk factor for cardiovascular diseases, e.g. coronary artery disease (CAD). But it has also been shown that diabetes can cause heart failure independently of ischemic heart disease (IHD) by causing diabetic cardi
Externí odkaz:
https://doaj.org/article/3693c02e4e96473b92104f24b6ddea8c
Publikováno v:
BMJ Open, Vol 9, Iss 10 (2019)
Introduction Acute pulmonary embolism (PE) is a frequent life-threatening event and an important cause of hospitalisation, morbidity and mortality worldwide. Limited information on the long-term course of PE patients is available so far. The Lungenem
Externí odkaz:
https://doaj.org/article/847745f994894d4489a55b8c5a8413f0
Autor:
Fabian Geissenberger, Florian Schwarz MD, Michael Probst MD, Sabine Haberl PhD, Stefanie Gruetzner MD, Thomas Kroencke MD, Wolfgang von Scheidt MD, Thomas M. Berghaus MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
D-dimer might be correlated with prognosis in pulmonary embolism (PE). The predictive value of plasma D-dimer for disease severity and survival was investigated in the lowest and highest D-dimer quartile among 200 patients with PE. Patients with high
Externí odkaz:
https://doaj.org/article/70700682c5c4471285e4361d3127ce26
Autor:
Matthias Pauschinger, Stefan Störk, Christiane E. Angermann, Johann Bauersachs, Raffi Bekeredjian, Friedhelm Beyersdorf, Michael Böhm, Norbert Frey, Jan Gummert, Ingrid Kindermann, Stefan Perings, P. Christian Schulze, Wolfgang von Scheidt, Philip Raake
Publikováno v:
Der Kardiologe. 16:142-159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeb536280ea7feb2a5872b994e43ccf3
https://doi.org/10.1007/s12181-022-00530-y
https://doi.org/10.1007/s12181-022-00530-y
Autor:
Wolfgang von Scheidt
Publikováno v:
Aktuelle Kardiologie. 10:310-315
ZusammenfassungEine evidenzbasierte medikamentöse Therapie der diastolischen Herzinsuffizienz (HFpEF/HFmrEF) ist bislang, im Gegensatz zur systolischen Herzinsuffizienz (HFrEF), nicht etabliert. Die ESC-Leitlinien 2016 empfehlen als einzige Substanz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffdf43ad15f18a12cd14837827b1100a
https://doi.org/10.1055/a-1506-2924
https://doi.org/10.1055/a-1506-2924